Skip to content


EPFL Bioengineering & Technology Platform

Share this actor

The BET platform aims to serve as a bidirectional bridge between the biomedical and EPFL research communities, to develop and share expertise in the space of translational bioengineering.

BET enables your translational research with the latest technologies and know-how coming out of EPFL and the larger engineering community.
BET accelerates  engineering of innovative assays and technologies by facilitating access to the clinical and translational landscape and expertise.


Primary Therapeutic Areas

1.20 Analytical & Diagnostic

1.22 Biosystems (Biochips-BioMems)

1.23 Cell Culture

1.26 Diagnostic technology

1.31 Other R&D Services

1.32 Screening

1.54 Drug Discovery & Delivery

1.56 Imaging

1.62 Other Devices

1.66 3D-Printing

3.4 Personalized Medicine

4.0 Consulting & Services

5.00 Biomaterials

5.01 Biosensor & DBS

5.04 Electronic (Biochip,Bioelectronic,part..)

5.3 Laboratory

5.30 Engineering & Design

5.31 Laboratory Instr. & Device

5.32 R&D Device

Business model

3. Academic & Research Institution

3.1 University & HES

Organization Type

Academic & Research Institution


Visit website


All or unlisted Domain, Oncology

Main sector

Research Institutes


Bioengineering and Technology platform (BET) - EPFL Swiss Federal Institute of Technology,
1005 Lausanne / VD